It is my intention to try and expedite the deliberations here tonight. In that regard, my thought would be to make a statement, hopefully, shedding some light on this amendment. I know Senator Pryor has worked so hard in this area. He wants to make a statement, and then it will be my intention to withdraw the amendment. I withdraw it reluctantly, because I think it needs to be considered and dealt with as soon as possible. But I am persuaded that we will not have some votes that we need to adopt it if we insist on attaching it to this measure. Having said that, let me simply outline the issue that is before us. It is well described in a New York Times editorial of February 28. I will quote a portion of that, because I think it is quite succinct and to the point: Congress finds it hard to remedy the simplest mistakes when powerful corporate interests are at stake. In 1974, when Congress approved a new trade pact with more than 100 other countries, it unintentionally handed pharmaceutical drug companies windfall profits. More than a year later, Congress has yet to correct the error.
Editor's note · Context
Discussing the need to address issues related to a trade pact and its impact on pharmaceutical companies.
Share
More from Sherrod Brown
I rise in support of H.R. 5457, the Strengthening Agency Management and Oversight of Software Assets Act. The SAMOSA Act is a straightforward, good-government bill that has strong bipartisan support from members of the Oversight Committee…
The crypto lobby has deep pockets, openly threatening lawmakers they deem aren’t sufficiently pro-crypto.
more and more I am troubled by a simple question: Will Donald Trump be the last President ever elected by a free and fair election? That certainly seems to be the plan. In 2024, Donald Trump said: Get out and vote, just this time. You…
I didn’t plan to run for office again, but when I see what’s going on, I know I can do something about it for Ohio.





